Key Takeaways
- Crude oil benchmarks surged as the U.S. and Iran engaged in tit-for-tat strikes in the Strait of Hormuz, with Brent crude trading near $97 per barrel.
- German Industrial Production fell a surprise 1.1% in July, significantly missing economist expectations of a 0.2% increase and highlighting the fragility of Europe’s largest economy.
- Novartis (NVS) and Ionis Pharmaceuticals (IONS) announced that their heart disease drug, pelacarsen, failed to meet its primary endpoint in a major Phase 3 trial.
- Amazon (AMZN) is rumored to have increased its 2026 capital expenditure to $220 billion to accelerate the procurement of AI server racks.
- Sweden's inflation (CPIF) slowed to 0.7% in August, missing the 0.9% forecast and potentially clearing the path for further interest rate cuts by the Riksbank.
Geopolitical Tensions Drive Energy Markets
Oil prices climbed sharply on Monday morning following military escalations in the Middle East. The U.S. launched strikes against three Iranian crude oil tankers over the weekend in retaliation for ballistic missile attacks on U.S. Navy warships. In response, Iran threatened to declare a new restricted zone in the Strait of Hormuz, raising fears of prolonged supply disruptions. Brent crude rose toward $97, while West Texas Intermediate (WTI) hovered around $92 in holiday-thinned trading due to the U.S. Labor Day holiday.
European Economic Fragility
German Industrial Production posted a disappointing 1.1% decline in July, reversing a brief period of resilience seen earlier in the year. The data from Destatis showed that manufacturing and industrial output are struggling to maintain momentum despite a recent uptick in factory orders. Analysts noted that the reading serves as a "stark reminder" of the cyclical headwinds facing the Eurozone.
In Scandinavia, Sweden’s Consumer Price Index with a fixed interest rate (CPIF) rose just 0.7% year-on-year in August, down from expectations of 0.9%. This cooling of inflationary pressure comes as the Swedish Budget Balance swung to a 61.9 billion SEK surplus in August, a significant improvement from the previous month's deficit.
Corporate Developments: Tech and Pharma
In the technology sector, rumors from supply chain sources indicate that Amazon (AMZN) has stepped up its AI infrastructure spending. The company has reportedly raised its 2026 capex to $220 billion, focusing on 3nm custom ASIC chips from TSMC (TSM) and increased production of AI server racks through partners like Wiwynn and Foxconn. Meanwhile, Apple (AAPL) is reportedly preparing to launch its first foldable device, potentially named the iPhone Ultra, with an initial rollout limited to North America due to yield challenges with hinges and foldable panels.
The pharmaceutical industry faced a setback as Novartis (NVS) and Ionis Pharmaceuticals (IONS) reported that their drug pelacarsen failed the Lp(a)HORIZON Phase 3 trial. Despite successfully lowering lipoprotein(a) levels, the treatment did not significantly reduce the risk of major cardiovascular events. The failure is a blow to the "Lp(a) hypothesis," which suggested that targeting this specific protein could provide a new avenue for heart disease prevention.
Real Estate and Infrastructure
In the UK, the Halifax House Price Index (now rebranded as the Lloyds House Price Index) showed a 0.4% year-on-year decline in August, a reversal from the 0.1% growth seen in July. Monthly prices fell by 0.2%, suggesting that the UK housing market remains under pressure from high borrowing costs.
Separately, the UAE Ministry of Investment signed a Memorandum of Understanding with Sunstone Development to establish a major anode production facility. The project, a joint venture with Emirates Global Aluminium (EGA), involves an investment of approximately $300 million and aims to produce 300,000 tonnes of anodes annually by 2028, reducing the UAE's reliance on imports.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.